BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 17414317)

  • 1. Cellular and functional characterization of immunoresistant human glioma cell clones selected with alloreactive cytotoxic T lymphocytes reveals their up-regulated synthesis of biologically active TGF-beta.
    Gomez GG; Kruse CA
    J Immunother; 2007 Apr; 30(3):261-73. PubMed ID: 17414317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation of immunoresistant human glioma cell clones after selection with alloreactive cytotoxic T lymphocytes: cytogenetic and molecular cytogenetic characterization.
    Gomez GG; Varella-Garcia M; Kruse CA
    Cancer Genet Cytogenet; 2006 Mar; 165(2):121-34. PubMed ID: 16527606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human alloreactive CTL interactions with gliomas and with those having upregulated HLA expression from exogenous IFN-gamma or IFN-gamma gene modification.
    Read SB; Kulprathipanja NV; Gomez GG; Paul DB; Winston KR; Robbins JM; Kruse CA
    J Interferon Cytokine Res; 2003 Jul; 23(7):379-93. PubMed ID: 14511464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoresistant human glioma cell clones selected with alloreactive cytotoxic T lymphocytes: downregulation of multiple proapoptotic factors.
    Gomez GG; Hickey MJ; Tritz R; Kruse CA
    Gene Ther Mol Biol; 2008 Jun; 12(1):101-110. PubMed ID: 19066635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of IFN-gamma and interleukin-1beta on major histocompatibility complex antigen and intercellular adhesion molecule-1 expression by 9L gliosarcoma: relevance to its cytolysis by alloreactive cytotoxic T lymphocytes.
    Schiltz PM; Gomez GG; Read SB; Kulprathipanja NV; Kruse CA
    J Interferon Cytokine Res; 2002 Dec; 22(12):1209-16. PubMed ID: 12581494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of human autotumor-reactive T-cell clones obtained from tumor-infiltrating lymphocytes in liver metastasis of gastric carcinoma.
    Shimizu Y; Weidmann E; Iwatsuki S; Herberman RB; Whiteside TL
    Cancer Res; 1991 Nov; 51(22):6153-62. PubMed ID: 1718596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cellular immunotherapy for malignant glioma].
    Okamoto Y; Yamashita J
    Nihon Rinsho; 2005 Sep; 63 Suppl 9():557-62. PubMed ID: 16201581
    [No Abstract]   [Full Text] [Related]  

  • 8. Gamma interferon transduced 9L gliosarcoma. Cytokine gene therapy and its relevance to cellular therapy with alloreactive cytotoxic T lymphocytes.
    Paul DB; Read SB; Kulprathipanja NV; Gomez GG; Kleinschmidt-DeMasters BK; Schiltz PM; Kruse CA
    J Neurooncol; 2003; 64(1-2):89-99. PubMed ID: 12952290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of transforming growth factor-beta 2-specific phosphorothioate-anti-sense oligodeoxynucleotides in reversing cellular immunosuppression in malignant glioma.
    Jachimczak P; Bogdahn U; Schneider J; Behl C; Meixensberger J; Apfel R; Dörries R; Schlingensiepen KH; Brysch W
    J Neurosurg; 1993 Jun; 78(6):944-51. PubMed ID: 8487077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crosstalk between keratinocytes and T lymphocytes via Fas/Fas ligand interaction: modulation by cytokines.
    Arnold R; Seifert M; Asadullah K; Volk HD
    J Immunol; 1999 Jun; 162(12):7140-7. PubMed ID: 10358159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of transforming growth factor-beta and interleukin-10 secretion from malignant glioma cells by cytokines and anticancer drugs.
    Naganuma H; Sasaki A; Satoh E; Nagasaka M; Nakano S; Isoe S; Nukui H
    J Neurooncol; 1998 Sep; 39(3):227-36. PubMed ID: 9821108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutaneous T cell lymphoma reactive CD4+ cytotoxic T lymphocyte clones display a Th1 cytokine profile and use a fas-independent pathway for specific tumor cell lysis.
    Echchakir H; Bagot M; Dorothée G; Martinvalet D; Le Gouvello S; Boumsell L; Chouaib S; Bensussan A; Mami-Chouaib F
    J Invest Dermatol; 2000 Jul; 115(1):74-80. PubMed ID: 10886511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T cell-mediated cytotoxicity of human gliomas: a tumor necrosis factor-independent mechanism.
    Baltuch GH; Villemure JG; McCrea E; Antel JP
    Neurosurgery; 1994 Sep; 35(3):450-6; discussion 456. PubMed ID: 7800136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the in vitro sensitivity of human lymphoid and hematopoietic progenitors to L-leucyl-L-leucine methyl ester.
    Pecora AL; Bordignon C; Fumagalli L; Radziejewski C; Small TN; Pekle K; O'Reilly RJ; Keever CA
    Transplantation; 1991 Feb; 51(2):524-31. PubMed ID: 1994549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous expression of transforming growth factor beta1 inhibits growth and tumorigenicity and enhances Fas-mediated apoptosis in a murine high-grade glioma model.
    Ashley DM; Kong FM; Bigner DD; Hale LP
    Cancer Res; 1998 Jan; 58(2):302-9. PubMed ID: 9443409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunomodulatory effects of interferons on target human gliosarcoma cells in the tumor-specific CTL- and LAK-mediated cytolysis].
    Miyatake S; Kondou S; Aoki T; Iwasaki K; Ohyama K; Ootsuka S; Oda Y; Kikuchi H
    No Shinkei Geka; 1991 Nov; 19(11):1053-9. PubMed ID: 1762655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-2 induces Fas ligand/Fas (CD95L/CD95) cytotoxicity in CD8+ and CD4+ T lymphocyte clones.
    Esser MT; Dinglasan RD; Krishnamurthy B; Gullo CA; Graham MB; Braciale VL
    J Immunol; 1997 Jun; 158(12):5612-8. PubMed ID: 9190908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions of the allogeneic effector leukemic T cell line, TALL-104, with human malignant brain tumors.
    Gomez GG; Read SB; Gerschenson LE; Santoli D; Zweifach A; Kruse CA
    Neuro Oncol; 2004 Apr; 6(2):83-95. PubMed ID: 15134622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD2/LFA-3 or LFA-1/ICAM-1 but not CD28/B7 interactions can augment cytotoxicity by virus-specific CD8+ cytotoxic T lymphocytes.
    de Waal Malefyt R; Verma S; Bejarano MT; Ranes-Goldberg M; Hill M; Spits H
    Eur J Immunol; 1993 Feb; 23(2):418-24. PubMed ID: 7679643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving alloreactive CTL immunotherapy for malignant gliomas using a simulation model of their interactive dynamics.
    Kronik N; Kogan Y; Vainstein V; Agur Z
    Cancer Immunol Immunother; 2008 Mar; 57(3):425-39. PubMed ID: 17823798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.